Mirae Asset Global Etfs Holdings Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,270 shares of HRMY stock, worth $623,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,270Holding current value
$623,791% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
228Shares Held
45.4MCall Options Held
48.2KPut Options Held
61.5K-
Valor Management LLC Chicago, IL11.2MShares$430 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$224 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$135 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$99.9 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$96.2 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.27B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...